MaxCyte
MXCT
$3.39
Share price
8.58%
Change (1 day)
-39.19%
Change (1 year)
Categories
Revenue for MaxCyte (MXCT)
Revenue in 2024 (TTM): S$51.72 Million
According to MaxCyte's latest financial reports the company's current revenue (TTM 
) is S$51.78 Million. a decrease over the revenue in the year 2023 that were of S$54.52 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for MaxCyte from 2021 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | S$52.5 M | -3.71% |
| 2023 | S$54.52 M | -8.1% |
| 2022 | S$59.33 M | 29.5% |
| 2021 | S$45.82 M |